Kidney/Rene (C64.9) - Recurrent renal carcinoma mimicking a goitre: a case report / Gozzo da carcinoma renale recidivo: un caso clinico
Keywords:
thyroid metastases, clear cell renal carcinoma, total thyroidectom, metastasi tiroidee, carcinoma renale a cellule chiare, tiroidectomia totaleAbstract
Although the thyroid is a high vascularised gland, it is not a common target of metastases from extraglandular cancer. We reported a case of a 70 year-old woman who underwent total thyroidectomy for multinodular goitre. In the patient’s clinical history a nephrectomy was carried out 2 years before due to unspecified causes. The histopathological examination of the thyroid showed a pattern compatible with clear cell renal carcinoma metastasis. The patient’s relatives revealed, when questioned again, that the nephrectomy was due to the presence of a clear renal cell carcinoma keep concealed to the patient. Thanks to a timely intervention, the mass was removed and a better survival was guaranteed to the patient.Gozzo da carcinoma renale recidivo: un caso clinico
Sebbene la tiroide sia una ghiandola altamente vascolarizzata, essa non è sede comune di metastasi di tumori extraghiandolari. In questo articolo riportiamo un caso di una settantenne sottoposta ad un intervento di tiroidectomia totale per gozzo multinodulare. Dalla storia clinica della paziente risultava una nefrectomia eseguita 2 anni prima per cause sconosciute. L’esame istopatologico della ghiandola asportata metteva in evidenza un pattern compatibile con una metastasi da carcinoma renale a cellule chiare. Ad uno studio più approfondito della storia della paziente, i parenti confessavano che la nefrectomia era stata conseguente all’insorgenza di un carcinoma renale a cellule chiare tenuto nascosto alla paziente stessa. Grazie ad un intervento tempestivo, la massa è stata asportata ed è stata garantita una migliore sopravvivenza alla paziente.
Downloads
Published
Issue
Section
License
OPEN ACCESS
All the articles of the European Journal of Oncology and Environmental Health are published with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/). This means that the author(s) retain copyright, but the content is free to download, distribute and adapt for commercial or non-commercial purposes, given appropriate attribution to the original article.
The articles in the previous edition of the Journal (European Journal of Oncology) are made available online with open access under the CC-BY Creative Commons attribution license (the current version is CC-BY, version 4.0 http://creativecommons.org/licenses/by/4.0/).
Upon submission, author(s) grant the Journal the license to publish their original unpublished work within one year, and the non exclusive right to display, store, copy and reuse the content. The CC-BY Creative Commons attribution license enables anyone to use the publication freely, given appropriate attribution to the author(s) and citing the Journal as the original publisher. The CC-BY Creative Commons attribution license does not apply to third-party materials that display a copyright notice to prohibit copying. Unless the third-party content is also subject to a CC-BY Creative Commons attribution license, or an equally permissive license, the author(s) must comply with any third-party copyright notices.